Dr Danielle Borg

Honorary Research Fellow

Mater Research Institute-UQ
Faculty of Medicine

Overview

Dr Borg is the program coordinator for the QLD family cohort study at the Mater Research Institute. Her passion in medical research was sparked during her PhD in type 1 diabetes with a leading immunologist in Germany, at the Centre for Regenerative Therapies, Technische Universität Dresden. Her interest in chronic disease continued in Australia into type 2 diabetes with world-renowned, highly-cited biochemists and immunologists. She has over 10 years of research experience in the fields of Diabetes, Cell Transplantation, Cell Imaging and Biochemistry. Throughout her research career, she published peer-reviewed publications, obtained funding for projects, lectured and tutored various undergraduate subjects and enjoyed the collaborative nature of medical research.

Danielle’s interest lies in improving health outcomes to the community via the translation of innovative findings from basic and clinical research. This overarching interest prompted her move from discovery research to clinical research and study coordination after the birth of her first child. She thrives on scientific communication, mentoring undergraduate and RHD students, and is an avid believer in giving back to the wider scientific community. She has sat on numerous committees, continues to review grants and publications and has volunteered for several organisations. Danielle is excited to be a part of the Queensland Family Cohort study which will put QLD, her home state, on the map nationally for birth cohort studies.

Research Interests

  • Developmental Origins of Disease
  • Longitudinal pregnancy and birth cohort outcomes
  • Immunology and autoimmune diseases
  • Diabetes Development and Progression
  • Pancreatic islet dysfunction

Research Impacts

Dr Borg is an early-career scientist who has authored 30 peer-reiviewed publications in the field of Diabetes, Biomaterial Transplantation, Islet Transplantation, Stem Cell Biology, RAGE/AGE Biology, and Scientific Engagement. She has completed research positions in Germany and Australia and has contributed to organising committees for scientific outreach programs, conferences and global communities such as Graduate Women in Science. Dr Borg has been supported by a number of mentors throughout her career and is an avid believer in mentorship. She enjoys supporting indviduals find their passion for their career path. As the program coordinator of the Queensland Family Cohort she now has the ability to bring collaborating researchers from multiple insitutes together to share data generated by this newest birth cohort in Queensland whose outcomes will focus on a number of areas including five research themes- Environment and Lifestyle; Neurodevelopment, Learning and Mental Health; Genetics and Physiology; Pregnancy and Disease and Public Health and Health Services. This research will help provide a roadmap of the current health of Queenslanders of reproductive age and their children, inform targeted public health strategies to prevent disease and minimise environmental exposures, inform government health and environmental policies to ensure improved health outcomes and underpin health planning and the provision of more targeted health service delivery informed by data.

Publications

View all Publications

Supervision

  • Doctor Philosophy

  • (2020) Doctor Philosophy

  • (2020) Doctor Philosophy

View all Supervision

Publications

Journal Article

Conference Publication

  • Leech, Sophie M., Gilbert, Morgan, Clifton, Vicki, Rae, Kym, Borg, Danielle, Evans, Paul and Dekker, Marloes (2023). Composition of the Breastmilk Microbiome at 6 Weeks Postpartum. 70th Annual Meeting of the Society for Reproductive Investigation (SRI), Brisbane, QLD, Australia, 21-25 March 2023. Heidelberg, Germany: Springer.

  • Fotheringham, A. K., Bagger, J. I., Borg, D. J., McCarthy, D., Vilsboll, T., Knop, F. K. and Forbes, J. M. (2019). Exploring AGE and sRAGE regulation in response to oral and intravenous glucose loads in individuals with recently diagnosed type 2 diabetes. 55th Annual Meeting of the European Association for the Study of Diabetes (EASD), Barcelona, Spain, 16-20 September 2019 . New York, NY, United States: Springer.

  • Fotheringham, A. K., Solon-Biet, S. M., Mcmahon, A. C., Ballard, W. O., Ruohonen, K., Borg, D. J., Raubenheimer, D., Le Couteur, D. G., Simpson, S. J. and Forbes, J. M. (2017). Using the Geometric Framework to Explore the Longitudinal Effects of Dietary Macronutrient Consumption On Markers of Kidney Aging. HOBOKEN: WILEY.

  • McGuckin, Mike, Hasnain, Sumaira Z., Borg, Danielle J., Loudovaris, Thomas, Kay, Thomas W., Thomas, Helen E., Whitehead, Jonathon P., Forbes, Josephine M. and Prins, John B. (2015). IL-22-mediated suppression of islet inflammation. IPITA/IXA/CTS Joint Congress, Melbourne Australia, Nov 15-19, 2015. HOBOKEN: LIPPINCOTT WILLIAMS & WILKINS.

  • Leung, S. S.-Y., Borg, D. J., McCarthy, D., Zhuang, A., Fotheringham, A., Di Trapani, G., Groop, P.-H., Knip, M. and Forbes, J. (2015). Human soluble receptor for advanced glycation end products therapy reduces autoimmune diabetes in the non-obese diabetic mouse. Joint Annual Conference of the International Society for Pediatric and Adolescent Diabetes and Australasian Paediatric Endocrine Group (ISPAD+APEG 2015), Brisbane, QLD Australia, 7-10 October 2015. Hoboken, NJ USA: Wiley-Blackwell Publishing. doi: 10.1111/pedi.12309

  • Leung, Sherman S., Borg, Danielle J., Paul, Moumita, Sharland, Alexandra F. and Forbes, Josephine M. (2015). Gene Therapy Using Recombinant Adeno-Associated Virus Serotype 2/8 Liver-Directed Expression of Srage in Experimental Type 1 Diabetes. 9th Biennial Meeting of the Australasian-Gene-and-Cell-Therapy-Society (AGCTS), Parkville, VIC Australia, 29 April - 1 May 2015. Hoboken, NJ United States: Wiley-Blackwell.

  • Leung, Sherman, Borg, Danielle J., McCarthy, Domenica, Zhuang, Aowen, Forbes, Josephine and Ward, Micheal (2015). Recombinant human soluble receptor for advanced glycation end product therapy reduces autoimmune diabetes in the NOD mouse model. 75th Scientific Sessions of the American-Diabetes-Association, Boston, MA USA, 5-9 June 2015. Alexandria, VA USA: American Diabetes Association.

  • Borg, D. J., Leung, S., Zhuang, A., Fotheringham, A., McCarthy, D., Di Trapani, J., Groop, P. -H., Knip, M. and Forbes, J. (2015). Delivery of recombinant human soluble receptor for advanced glycation end products delays autoimmune diabetes in the NOD mouse model. 51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Stockholm, Sweden, 14-18 September 2015. Heidelberg, Germany: Springer. doi: 10.1007/s00125-015-3687-4

  • McGuckin, Mike, Hasnain, Sumaira Z., Borg, Danielle J., Loudovaris, Thomas, Kay, Thomas W., Thomas, Helen E., Whitehead, Jonathon P., Forbes, Josephine M. and Prins, John B. (2015). IL-22-MEDIATED SUPPRESSION OF ISLET INFLAMMATION. Joint Congress of the International-Pancreas-and-Islet-Transplantation-Association, International-Xenotransplantation-Association and Cell-Transplant-Society, Melbourne Australia, Nov 15-19, 2015. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

  • Borg, D. J., McCarthy, D., Reeves, P., Ward, M. S., Fotheringham, A. K., Gallo, L. A., Harcourt, B. E., Agrawal, N., Steptoe, R. and Forbes, J. M. (2015). Short-term alagebrium chloride (ALT-711) therapy pre-diabetes for the treatment of Type I Diabetes. Immunology of Diabetes Society 14th International Congress, Munich, Germany, 12-16 April 2015.

  • Tesch, G. H., Sourris, K. C., Summers, S. A., Mccarthy, D., Ward, M. S., Borg, D. J., Gallo, L. A., Fotheringham, A. K., Pettit, A., Yap, F. Y. T., Harcourt, B. E., Tan, A. L. Y., Kausman, J. Y., Nikolic-Paterson, D. J., Kitching, A. R. and Forbes, J. M. (2014). Deficiency of rage in bone marrow cells reduces renal injury in diabetic mice. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne Australia, 25–27 August 2014. Richmond Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12301

  • Leung, C., Fotheringham, A. K., Zhuang, A., Borg, D. J., Ward, M. S., Coughlan, M. T., Mccarthy, D. A., Gallo, L. A., Harcourt, B. E. and Forbes, J. M. (2014). Flux of advanced glycation end products across the kidney as a contributor to renal disease in diabetes. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 25–27 August 2014. Richmond Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12302

  • Borg, D. J., Yap, F. Y. T., Fotheringham, A. K., Harcourt, B. E., McCarthy, D., Ward, M., Slattery, R., Coughlan, M. T., Kantharidis, P. and Forbes, J. M. (2013). Therapies which lower advanced glycation end products influence experimental autoimmune diabetes in a time dependent manner. 49th Annual Meeting of the European Association for the Study of Diabetes (EASD), Barcelona, Spain, 23 -27 September 2013. Heidelberg, Germany: Springer. doi: 10.1007/s00125-013-3012-z

Other Outputs

PhD and MPhil Supervision

Current Supervision

Completed Supervision